The International SCN8A Patient Registry: A Scientific Resource to Advance the Understanding and Treatment of a Rare Pediatric Neurodevelopmental Syndrome

J Registry Manag. 2023 Spring;50(1):4-10.

Abstract

Genetic variants in the SCN8A gene underlie a wide spectrum of neurodevelopmental phenotypes that range from severe epileptic encephalopathy to benign familial infantile epilepsy to neurodevelopmental delays with or without seizures. A host of additional comorbidities also contribute to the phenotypic spectrum. As a result of the recent identification of the genetic etiology and the length of time it often takes to diagnose patients, little data are available on the natural history of these conditions. The International SCN8A Patient Registry was developed in 2015 to fill gaps in understanding the spectrum of the disease and its natural history, as well as the lived experiences of individuals with SCN8A syndrome. Another goal of the registry is to collect longitudinal data from participants on a regular basis. In this article, we describe the construction and structure of the International SCN8A Patient Registry, present the type of information available, and highlight particular analyses that demonstrate how registry data can provide insights into the clinical management of SCN8A syndrome.

Keywords: developmental and epileptic encephalopathy; genetic variant; pediatric epilepsy; registry; sodium channel.

MeSH terms

  • Epilepsy* / epidemiology
  • Epilepsy* / genetics
  • Epilepsy* / therapy
  • Epilepsy, Generalized*
  • Humans
  • NAV1.6 Voltage-Gated Sodium Channel / genetics
  • Phenotype
  • Registries*
  • Seizures / genetics
  • Syndrome

Substances

  • NAV1.6 Voltage-Gated Sodium Channel
  • SCN8A protein, human

Grants and funding

Funding for this registry was provided by Neurocrine Biosciences, Praxis Precision Medicines, Xenon Pharmaceutical, Wishes for Elliott, and the Shay Emma Hammer Research Foundation.